Latest filings (excl ownership)
15-12G
Securities registration termination
27 Sep 23
8-K
Results of Operations and Financial Condition
27 Sep 23
8-K
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
15 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
26 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
DEFA14A
Additional proxy soliciting materials
10 May 23
DEF 14A
Definitive proxy
10 May 23
ARS
2022 FY
Annual report to shareholders
10 May 23
8-K
Results of Operations and Financial Condition
18 Apr 23
10-K
2022 FY
Annual report
14 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
8-K
Changes in Registrant's Certifying Accountant
22 Nov 22
8-K
Fuse Medical, Inc. Announces Third Quarter 2022 Financial Results
18 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
27 Jun 22
10-Q
2022 Q1
Quarterly report
12 May 22
DEFA14A
Additional proxy soliciting materials
10 May 22
DEF 14A
Definitive proxy
10 May 22
8-K
Departure of Directors or Certain Officers
8 Apr 22
10-K
2021 FY
Annual report
31 Mar 22
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
20 Dec 21
8-K
Departure of Directors or Certain Officers
3 Dec 21
8-K
Entry into a Material Definitive Agreement
12 Nov 21
10-Q
2021 Q3
Quarterly report
10 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 21
10-Q
2021 Q1
Quarterly report
12 May 21
DEFA14A
Additional proxy soliciting materials
27 Apr 21
DEF 14A
Definitive proxy
27 Apr 21
10-K
2020 FY
Annual report
31 Mar 21
8-K
Fuse Medical, Inc. Announces Exclusive Agreement with Orthovestments, LLC for Manufacturing & Commercialization of the Orbitum ™ Staple System
1 Feb 21
8-K
Other Events
20 Jan 21
8-K
FUSE MEDICAL, INC. ANNOUNCES LAUNCH OF FuseChoiceTM BIOLOGICS PORTFOLIO
22 Dec 20
10-Q
2020 Q3
Quarterly report
16 Nov 20
8-K
Fuse Medical, Inc. Files Quarterly Results on Form 10-Q and Provides Business Update In Response of COVID-19
14 Aug 20
10-Q
2020 Q2
Quarterly report
7 Aug 20
8-K
Fuse Medical, Inc. Announces Engagement of Armanino LLP
19 Jun 20
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 20
Latest ownership filings
4
Christopher C Reeg
16 Dec 22
4
Lawrence Scott Yellin
16 Dec 22
4
Mark W Brooks
16 Dec 22
4
Mark W Brooks
17 Nov 22
3
Lawrence Scott Yellin
26 May 22
5
Christopher C Reeg
23 Feb 22
5
Mark W Brooks
23 Feb 22
4
Renato V. Jr. Bosita
21 Dec 18
4
Ricky Raj S. Kalra
14 Dec 18
4
Mark W Brooks
14 Dec 18
4
Christopher C Reeg
14 Dec 18
4
William E McLaughlin III
14 Dec 18
4/A
Change in insider ownership (amended)
27 Nov 18
4/A
Christopher C Reeg
27 Nov 18
SC 13D/A
Fuse Medical, Inc.
13 Aug 18
SC 13D/A
Fuse Medical, Inc.
13 Aug 18
4
Change in insider ownership
3 Aug 18
4
Christopher C Reeg
3 Aug 18
3/A
Initial statement of insider ownership (amended)
8 Feb 18
3/A
Christopher C Reeg
8 Feb 18
3/A
Mark W Brooks
8 Feb 18
3/A
Initial statement of insider ownership (amended)
8 Feb 18
4
Mark W Brooks
8 Feb 18
4
Change in insider ownership
8 Feb 18
4/A
Mark W Brooks
8 Feb 18
4/A
Christopher C Reeg
8 Feb 18
4/A
Change in insider ownership (amended)
8 Feb 18
4/A
Mark W Brooks
8 Feb 18
4/A
Mark W Brooks
8 Feb 18
4/A
Christopher C Reeg
8 Feb 18
4
Renato V. Jr. Bosita
20 Dec 17
4
Christopher C Reeg
20 Dec 17
4
William E McLaughlin III
20 Dec 17
4
Mark W Brooks
20 Dec 17
4
Ricky Raj S. Kalra
20 Dec 17
4/A
William E McLaughlin III
20 Dec 17
4/A
Christopher C Reeg
20 Dec 17
4/A
Mark W Brooks
20 Dec 17
4/A
Renato V. Jr. Bosita
20 Dec 17
4/A
Ricky Raj S. Kalra
20 Dec 17